PTX:ASX
Prescient Therapeutics Ltd
A$0.065
arrow_downward
-1.52%(-0.0010) 1D
Oct 5, 11:32:36 AM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0.07
High
A$0.07
Low
A$0.06
Mkt. cap
70.10M
Avg. vol.
1.19M
Volume
231.57K
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
Open
A$0.07
High
A$0.07
Low
A$0.06
Mkt. cap
70.10M
Avg. vol.
1.19M
Volume
231.57K
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
News stories
From web sources and news partners
InteractiveCrypto
·
12 hours ago
The S&P 500 Looks Strong. Underneath, October Looks Thin.
Traders Union
·
6 hours ago
S&P500 has posted gains in nearly every November-through-June period since 1942, Lia Holmgren notes
FXLeaders
·
2 hours ago
Dow Jones and Nasdaq Futures Open Higher as Buyers Target New Records
Forbes
·
14 hours ago
S&P 500 Q3 Earnings Preview: Trends Investors Need To Watch
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorBiotechnology
Websiteptxtherapeutics.com